NCT05501093View on ClinicalTrials.gov

Diabetes Reversal and the Subgingival Microbiota

CompletedOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

March 11, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Diabetes type2Bariatric Surgery Candidate
Interventions
OTHER

sample collection

Blood, plaque, and other oral samples

Trial Locations (2)

19104

Temple University, Philadelphia

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

collaborator

Temple University

OTHER

collaborator

Ohio State University

OTHER

lead

University of Pennsylvania

OTHER

NCT05501093 - Diabetes Reversal and the Subgingival Microbiota | Biotech Hunter | Biotech Hunter